Delemarre-van de Waal H A
Academisch Ziekenhuis Vrije Universiteit, afd. Kindergeneeskunde, Amsterdam.
Ned Tijdschr Geneeskd. 1991 Dec 7;135(49):2330-3.
In male patients with hypogonadotropic hypogonadism development of the testicles may be brought about by means of pulsatile administration of LHRH. The results in 29 treated patients are described. The treatment lasted 53 weeks on average and in all patients led to a rise of the plasma levels of LH, FSH and testosterone, and to an increased testicular volume. Spermatogenesis started in 22 patients. The LHRH treatment induces the secretion of gonadotrophins and consequently, testicular steroidogenesis. This causes virilization to begin. Furthermore, under the influence of the FSH in particular, the tubules and spermatogenesis develop. Fertility may then be achieved. It is concluded that pulsatile LHRH treatment is a suitable method to induce development of the testicles, including spermatogenesis. Once spermatogenesis is initiated, HCG treatment can maintain and even improve this development.
在患有低促性腺激素性性腺功能减退的男性患者中,可通过脉冲式给予促性腺激素释放激素(LHRH)来促使睾丸发育。本文描述了29例接受治疗患者的结果。治疗平均持续53周,所有患者的促黄体生成素(LH)、促卵泡生成素(FSH)和睾酮的血浆水平均升高,睾丸体积增大。22例患者开始精子发生。LHRH治疗可诱导促性腺激素分泌,从而促进睾丸类固醇生成。这会引发男性化。此外,特别是在FSH的影响下,曲细精管和精子发生得以发展。随后可实现生育能力。结论是,脉冲式LHRH治疗是诱导睾丸发育(包括精子发生)的合适方法。一旦启动精子发生,人绒毛膜促性腺激素(HCG)治疗可维持甚至改善这种发育。